Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Boehringer Ingelheim - Emerging therapies in clinical practice: What are the patient perspectives on the future of lung cancer treatment?

Panel discussion and audience Q&A

Date

15 Sep 2024

Session

Boehringer Ingelheim - Emerging therapies in clinical practice: What are the patient perspectives on the future of lung cancer treatment?

Topics

Basic Science;  Cancer Research

Tumour Site

Thoracic Malignancies

Presenters

Martin Wermke, Gerrina Ruiter, Jon Zugazagoitia

Authors

M. Wermke1, G. Ruiter2, J. Zugazagoitia3

Author affiliations

  • 1 Early Clinical Trial Dept., Dresden University, 01187 - Dresden/DE
  • 2 Pulmonology, NKI-AVL - Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, 1066 CX - Amsterdam/NL
  • 3 Medical Oncology Dept., Hospital Universitario 12 de Octubre, 28041 - Madrid/ES

Resources

This content is available to ESMO members and event participants.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.